Moreover, salvaging PAD4 expression in MCF-7/ADR cells has been shown to promote the nuclear accumulation of GSK3β and p53, which activates proapoptotic gene expression, thereby resensitizing cancer cells to adverse drug reaction (ADR)-induced apoptosis and reversing drug resistance [90]. The gene discussed is TP53; the disease is cancer.